You're using a free limited version of DrugPatentWatch: Upgrade for Complete Access

Last Updated: June 21, 2025

Details for Patent: 10,730,883


✉ Email this page to a colleague

« Back to Dashboard


Which drugs does patent 10,730,883 protect, and when does it expire?

Patent 10,730,883 protects RINVOQ and is included in one NDA.

This patent has fifty patent family members in thirteen countries.

Summary for Patent: 10,730,883
Title:Processes for the preparation of (3S,4R)-3-ethyl-4-(3H-imidazo[1,2-a]pyrrolo[2,3-e]-pyrazin-8-yl)-N-(2,2,2- -trifluoroethyl)pyrrolidine-1-carboxamide and solid state forms thereof
Abstract: The present disclosure relates to processes for preparing (3S,4R)-3-ethyl-4-(3H-imidazo[1,2-a]pyrrolo[2,3-e]pyrazin-8-yl)-N-(2,2,2-- trifluoroethyl)pyrrolidine-1-carboxamide, solid state forms thereof, and corresponding pharmaceutical compositions, methods of treatment (including treatment of rheumatoid arthritis), kits, methods of synthesis, and products-by-process.
Inventor(s): Allian; Ayman (Newbury Park, CA), Jayanth; Jayanthy (Buffalo, IL), Klunder; Ben (Ludwigshafen, DE), Mohamed; Mohamed-Eslam F. (Gurnee, IL), Othman; Ahmed A. (Waukegan, IL), Marroum; Patrick J. (Springfield, VA), Mayer; Peter T. (Libertyville, IL)
Assignee: AbbVie Inc. (North Chicago, IL)
Application Number:16/787,251
Patent Claim Types:
see list of patent claims
Compound; Dosage form;
Patent landscape, scope, and claims:

Analyzing the Scope and Claims of United States Patent 10,730,883

Introduction

United States Patent 10,730,883, titled "Processes for the preparation of (3S,4R)-3-ethyl-4-(3H-imidazo[1,2-a]pyrrolo[2,3-e]pyrazin-8-yl)-N-(2,2-difluoroethyl)pyrrolidine-2-carboxamide," is a patent that discloses specific chemical processes for the synthesis of a particular compound. This analysis will delve into the scope, claims, and the broader patent landscape surrounding this patent.

Patent Overview

The patent, assigned to a specific entity (though not specified in the provided sources), outlines detailed methods for preparing a complex organic compound. Here are some key aspects:

Compound and Purpose

The patent focuses on the synthesis of (3S,4R)-3-ethyl-4-(3H-imidazo[1,2-a]pyrrolo[2,3-e]pyrazin-8-yl)-N-(2,2-difluoroethyl)pyrrolidine-2-carboxamide, a compound potentially used in pharmaceutical applications, such as treating diseases like rheumatoid arthritis[4].

Claims

The claims section of the patent is crucial as it defines the scope of protection. Here, the claims likely include:

  • Independent Claims: These are the broadest claims that define the invention. They typically include the essential features of the process.
  • Dependent Claims: These claims are narrower and build upon the independent claims, adding additional features or limitations.
  • Process Claims: Given the nature of the patent, these claims would detail the specific steps and conditions for synthesizing the compound.

Scope of the Patent

The scope of the patent is determined by the claims and the description provided in the specification.

Claim Language and Scope

The scope is measured by metrics such as independent claim length and independent claim count. Research suggests that narrower claims at publication are associated with a higher probability of grant and a shorter examination process[3].

Specific Processes and Conditions

The patent describes various processes, including synthesis reactions, crystallization methods, and the use of specific reagents and solvents. For example, it mentions the use of tetrahydrofuran, ethyl acetate, and other chemicals in the synthesis process[4].

Patent Landscape

Understanding the broader patent landscape is essential for assessing the novelty, non-obviousness, and potential infringement issues.

Prior Art

The patent landscape includes prior art that could affect the validity of the patent. This includes other patents, published applications, and scientific literature related to similar compounds and synthesis methods. Tools like the USPTO's Patent Public Search and international databases such as the European Patent Office's esp@cenet can be used to search for prior art[1].

Global Dossier and International Filings

The Global Dossier service allows users to view the file histories of related applications from participating IP Offices, which can provide insights into the global patent family and any office actions or citations relevant to the patent[1].

Citation Data

The Common Citation Document (CCD) application consolidates citation data from participating IP Offices, helping to identify prior art cited by multiple offices for the same invention. This can be crucial in assessing the novelty and non-obviousness of the claimed processes[1].

Legal and Regulatory Considerations

Patent claims are subject to legal interpretations and regulatory scrutiny.

Claim Construction

Claim construction is a critical legal issue, as seen in cases like VASCULAR SOLUTIONS LLC v. MEDTRONIC, INC., where the court must interpret the meaning of claim terms. This process involves determining the scope of the claims and ensuring they are clear and definite[2].

Validity and Infringement

The patent is presumed valid under 35 U.S.C. ยง 282, but it can be challenged through inter partes review (IPR) or other post-grant proceedings. The district court's findings on claim construction and validity can significantly impact the patent's enforceability[2].

Practical Implications

For businesses and researchers, understanding the scope and claims of this patent is vital.

Licensing and Collaboration

Companies may need to negotiate licenses or collaborations to use the patented processes. The clarity and scope of the claims will influence these negotiations.

Research and Development

Researchers must ensure that their work does not infringe on the patented processes. Conducting thorough patent searches and analyzing the claims can help in designing around existing patents.

Key Takeaways

  • Detailed Processes: The patent outlines specific chemical processes for synthesizing a complex compound.
  • Claim Scope: The claims define the scope of protection and are critical for determining infringement and validity.
  • Prior Art and Citation Data: Understanding prior art and citation data is essential for assessing the novelty and non-obviousness of the claimed processes.
  • Legal Considerations: Claim construction and validity are subject to legal interpretations and regulatory scrutiny.
  • Practical Implications: The patent's scope affects licensing, collaboration, and research activities.

FAQs

  1. What is the main compound described in United States Patent 10,730,883? The main compound is (3S,4R)-3-ethyl-4-(3H-imidazo[1,2-a]pyrrolo[2,3-e]pyrazin-8-yl)-N-(2,2-difluoroethyl)pyrrolidine-2-carboxamide.

  2. How can one search for prior art related to this patent? One can use tools like the USPTO's Patent Public Search, Global Dossier, and international databases such as the European Patent Office's esp@cenet.

  3. What is the significance of claim construction in patent law? Claim construction is crucial as it determines the scope of the claims and ensures they are clear and definite, impacting the patent's enforceability.

  4. Can the validity of the patent be challenged? Yes, the validity of the patent can be challenged through inter partes review (IPR) or other post-grant proceedings.

  5. Why is understanding the patent landscape important? Understanding the patent landscape helps in assessing the novelty, non-obviousness, and potential infringement issues, which are critical for research, development, and business strategies.

Sources

  1. USPTO - Search for patents
  2. VASCULAR SOLUTIONS LLC v. MEDTRONIC, INC.
  3. Patent Claims and Patent Scope - SSRN
  4. US10730883B2 - Processes for the preparation of (3S,4R)-3-ethyl-4-(3H-imidazo[1,2-a]pyrrolo[2,3-e]pyrazin-8-yl)-N-(2,2-difluoroethyl)pyrrolidine-2-carboxamide

More… ↓

⤷  Try for Free


Drugs Protected by US Patent 10,730,883

Applicant Tradename Generic Name Dosage NDA Approval Date TE Type RLD RS Patent No. Patent Expiration Product Substance Delist Req. Patented / Exclusive Use Submissiondate
Abbvie RINVOQ upadacitinib TABLET, EXTENDED RELEASE;ORAL 211675-002 Jan 14, 2022 RX Yes No 10,730,883 ⤷  Try for Free Y ⤷  Try for Free
>Applicant >Tradename >Generic Name >Dosage >NDA >Approval Date >TE >Type >RLD >RS >Patent No. >Patent Expiration >Product >Substance >Delist Req. >Patented / Exclusive Use >Submissiondate

International Family Members for US Patent 10,730,883

Country Patent Number Estimated Expiration Supplementary Protection Certificate SPC Country SPC Expiration
Australia 2016340167 ⤷  Try for Free
Australia 2020359635 ⤷  Try for Free
Australia 2021236570 ⤷  Try for Free
Australia 2023251492 ⤷  Try for Free
Brazil 112018007677 ⤷  Try for Free
Brazil 112022005765 ⤷  Try for Free
>Country >Patent Number >Estimated Expiration >Supplementary Protection Certificate >SPC Country >SPC Expiration

Make Better Decisions: Try a trial or see plans & pricing

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.